TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
(NASDAQ:TGTX) NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that it has completed its previously authorized $100 million share repurchase progr...
Is the timing of the repurchase aligned with expected earnings releases or catalyst events that could amplify the stock’s momentum?
What does the initiation of a new $100 million repurchase program signal about management’s confidence and how does it compare to peer buyback activity in the biotech sector?
How will the completed $100 million buyback affect TG Therapeutics’ short‑term liquidity and valuation metrics?
11 days ago